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New Flavonoids from the Saudi Arabian Plant Retama raetam 
which Stimulate Secretion of Insulin and Inhibit -Glucosidase 
Mohammad Nur-e-Alam,a* Muhammad Yousaf,a Ifat Parveen,b Rahman M. Hafizur,c Usman 
Ghani,d Sarfaraz Ahmed,a Abdul Hameed,c Michael D. Threadgillb,e and Adnan J. Al-Rehailya* 
Retama raetam is a bush which is a member of the family Fabaceae. It  is used traditionally in North Africa and Saudi 
Arabia for the treatment of diabetes. Several flavonoids and alkaloids were already known from this plant. 
Chromatographic fractionation and purification led to the isolation of three new derivatives of prenylated flavones, 
retamasin C-E and four new derivatives of prenylated isoflavones, retamasin F-I, in addition to two isoflavones which had 
not previously been reported in this plant. Particularly interesting structures included isoflavones containing 3,5-dihydro-
2H-2,5-methanobenzo[e][1,4]dioxepine and 3a,8b-dihydro-7-hydroxyfuro[3,2-b]benzo[2,1-d]furan units, both of which are 
new amongst natural product flavonoids. Five new examples (two flavones and three isoflavones) strongly enhanced the 
glucose-triggered release of insulin by murine pancreatic islets and one isoflavone was a potent inhibitor of -glucosidase. 
This study may rationalise the traditional medicinal use of R. raetam and provides new leads for drug design in the 
treatment of diabetes. 
Introduction 
Retama raetam (Forsk.) Webb & Berthel is a plant common in 
North Africa, countries of the Eastern Mediterranean and in 
the Middle East,1,2 including Saudi Arabia, and is a member of 
the family Fabaceae. It is particularly abundant in desert areas 
and is known locally as R’tm or broom bush. It flourishes in 
arid desert areas, where it stabilises the land and is a forage 
plant for camels, goats and sheep.3 However, ingestion by 
livestock leads to toxicity.2 In folk medicine in Saudi Arabia and 
Morocco, this plant has been used to treat diabetes and hyper-
tension.4 This traditional therapeutic activity has been borne 
out in experimental studies in rodents, where aqueous 
extracts of the plant lowered the concentrations of glucose 
and lipids in normal and streptozotocin-treated rats4,5 and 
caused acute diuresis in normal rats.6 Anti-oxidant, anti-micro-
bial, anti-viral and insecticidal activities have also been repor-
ted.4,7 One mechanism for the observed hypoglycaemic activity 
in rats has been suggested to be inhibition of renal re-uptake 
of glucose,8 whereas a methanol extract showed antidiabetic 
activity in the same species which was attributed to increasing 
glucose-stimulated release of insulin by the pancreas and to 
diminution of absorption of glucose in the intestine.9 
There is a need to identify the antidiabetic / hypoglycaemic 
compounds present in R. raetam for potential development 
into effective treatments for this major disease, a growing 
cause of death and disability across the world. Isolation of the 
active compounds is key, as the plant, crude extracts and folk-
lore preparations have led to significant toxicity to animals2 
and humans.10 Amongst other classes of compounds, quinoliz-
idine and other alkaloids have been isolated (including cytisine, 
L-anagyrine, sparteine and lupinine), which may be responsible 
for this toxicity.11 Pinitol, a cyclitol component of R. raetam, is 
a known hypoglycaemic agent.12 However, the flavonoids have 
been most extensively studied as components of this plant. In 
addition to the simple compounds daidzein, naringenin, 
apigenin, kaempferol, quercetin and orientin (and their 
glycosides),13 luteolin 4′-neohespiridoside has been identified 
as a more complex flavone-O-glycoside in this plant.14,15 The 
flavone-C-glycoside saponarin was characterised by Kassem et 
al.,15 whereas C-isoprenyl units can be recognised in the R. 
raetam pyranoflavones atalantoflavone16 and 4′,5-dihydroxy-
(3′′,4′′-dihydro-3′′,4′′dihydroxy)-2′′,2′′-dimethylpyrano-
(5′′,6′′:7,8)-flavone,14 in the furanoflavone retamasin B16 and in 
the open-chain flavones licoflavone C16 and ephedroidin.16 The 
isoprenyl unit is truncated in retamasin B.16 The analogous C-
glycosyl isoflavone genistein 8-C-glucoside15 and the pyrano-
isoflavones derrone16 and hydroxyderrone16 have also been 
found in R. raetam. 
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Flavonoids have a very wide range of biological and thera-
peutic activities. In this study, further clarification was sought 
of the compounds in R. raetam which are responsible for its 
antidiabetic activity. The chloroform extract of the aerial parts 
of the plant was fractionated chromatographically. Seven new 
flavonoids (1-3,5-8), one known flavone (4) and two known 
isoflavones (9,10) (Figure 1) were isolated and characterised 
spectroscopically, each derived from a flavone or isoflavone 
carrying a modified C5 isoprene unit. All compounds were 
examined for stimulation of secretion of insulin from islets 
isolated from murine pancreas and seven were selected for 
assessment for inhibition of -glucosidase. 
Results & discussion 
The dried aerial parts of R. raetam were extracted with 
chloroform and the solvent was evaporated. This residue was 
partitioned between hexane and acetonitrile. Chromatography 
of the acetonitrile fraction, followed by reverse-phase prepar-
ative HPLC on a C18 column, afforded ten pure compounds 1-
10. Their structures were elucidated using 1D and 2D NMR and 
HRESIMS data. The absolute configurations of the chiral 
compounds 1,2,5-9 cannot be determined from these data. 
The HRESIMS of 1 showed a peak in positive mode at m/z 
355.1156, corresponding to [M + H]+ (calcd 355.1181) for the 
molecular formula C20H18O6. Ions were also seen at m/z 
377.0982 [M + Na]+ (calcd 377.1001) and m/z 709.2250 [2 M + 
H]+ (calcd 709.2285). The HRESIMS in negative mode 
Figure 1. Structures of flavonoids newly isolated from R. raetam. 
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confirmed the formula, with peaks at m/z 353.1018 [M – H]- 
(calcd 353.1025), m/z 707.2125 [2 M – H]- (calcd 707.2128), 
 and m/z 753.2179 [2 M + formate]- (calcd 753.2183), in 
addition to a peak at 389 [M + 35Cl]-. The NMR spectra showed 
the appropriate numbers of 1H and 13C signals. The core 
structure was shown, by a combination of NMR techniques, to 
be a flavone. Specifically, H-3 (H 6.80) and H-6 (H 6.28) both 
showed HMBC cross-peaks to C-4a (C 104.68). 
The 1H NMR spectrum of 1 (Table 1) showed doublets at H 
7.94 (J 8.2 Hz) (C 128.94) and H 6.95 (J 8.2 Hz) (C 116.49),  
each integrating for 2 H. These signals corresponded to H-2’,6’ 
(C-2’,6’) and H-3’,5’ (C-3’,5’), respectively. The phenolic OH 
signal at H 13.19 showed HMBC correlations with C-6 (C 
93.95), C-4a (C 104.68) and C-5 (C 161.78), with a weak cross-
peak to the ketone (C 182.30); these located the signal at H 
13.19 as being due to HO-5, which was deshielded by H-
bonding to the ketone oxygen. The signal at H 10.45 was thus 
due to the phenol at C-4’, rationalising the H chemical shifts 
for H-2’,3’,5’,6’. These data, together with the H and C for 
ring A, confirmed that the flavone has a 4′,5,7-oxygenation 
pattern. The methylene protons (H 3.29, m) correlated with 
the 13C signal (C 26.49) in the HSQC spectrum and with C-7 (C 
166.74), C-8 (C 104.48) and C-8a (C 152.20) in the HMBC 
spectrum, which identified this methylene (CH2-1”) as attached 
at C-8. A COSY cross-peak from H-1” identified H-2” (H 4.80), 
with HSQC linking this to C-2” (C 92.05). H-2” gave HMBC 
cross-peaks to C-8 (C 104.48) and C-7 (C 166.74) of the 
flavone; both of these were three-bond correlations, which 
confirmed the fusion of the dihydrofuran ring. H-2” also 
correlated in HMBC through two bonds with C-1” (C 26.49) 
and quaternary C-3” (C 70.53) and through three bonds with 
the methyl carbons C-4” (C 25.35) and C-5” (C 26.25). These 
two methyl groups were diastereotopic; however, although 
the carbon chemical shifts were different, the 1H chemical 
shifts were identical (H 1.18). C-3” also carries an OH group 
(HO-3” H 4.74), as shown by the downfield 13C chemical shift. 
This OH signal shows HMBC correlations with C-2”, C-3”, C-4” 
and C-5”. Together, these spectroscopic data confirmed the 
structure of 1 (retamasin C), a novel compound.  
The positive-ion HRESIMS of 2 showed [M + H]+ at m/z 
355.1161 (calcd 355.1181), showing that it was an isomer of 1. 
Ions were also observed at m/z 377.0982 [M + Na]+ (calcd 
377.1001) and m/z 337.1132 [M + H – H2O]+ (calcd 337.1076); 
the latter indicated the presence of an aliphatic alcohol. In the 
negative-ion HRESIMS, ions were detected at m/z 353.1023 [M 
– H]- (calcd 353.1025), m/z 707.2126 [2 M – H]- (calcd 
707.2128) and m/z 743.1893 [2 M + 35Cl]- (calcd 743.1900), 
confirming the formula. The NMR spectra (Table 1) showed the 
appropriate numbers of 1H and 13C signals. As for 1, H-3 (H 
6.82, s) and H-6 (H 6.13, s) both correlated in the HMBC 
spectrum with C-4a (C 104.98), confirming 2 as a flavone and 
not an isoflavone. 
The IR spectrum of 2 indicated OH (3341 cm-1) and a 
conjugated aryl ketone (1645 cm-1). 13C and HSQC NMR 
Figure 2. A: MM2-minimised structures of 1 and 2, showing conformations of the dihydrofuran and dihydropyran rings, respectively. The 
pseudoequatorial location of H-2” in 2 is also shown. B: Two views of the MM2-minimised structure of the HO-exo diastereoisomer of 5, 
showing tentative assignments of the 1H NMR signals for H-5′′ (upper) and the dihedral angle between (H-2”)–(C-2”) and (C-5”)–(C-3”) 
(lower), suggesting this diastereoisomer. C: Diastereoisomeric identity of 6 demonstrated by NOESY spectroscopy. D: Overlay of the 
MM2-minimised structures of the two diastereoisomers of 8. 
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showed five methine signals, one methylene signal, two 
methyl signals and ten quaternary signals. The diastereotopic 
CH2 protons resonated at H 2.73 and H 3.05, correlating in 
HSQC with the methylene C-1” (C 25.32). HMBC cross-peaks 
between these H-1” signals and the downfield aromatic carbon 
signals at C 159.3 (C-7) and C 154.82 (C-8a) linked this 
methylene to C-8, supported by weaker two-bond HMBC 
cross-peaks from these H-1” methylene protons to C-8. The 
COSY spectrum showed cross-peaks between these H-1” 
signals and the signal at H 3.75 (HSQC to C 67.28). These 
chemical shifts indicated that this carbon (C-2”) also carried an 
oxygen, confirmed as OH by the COSY cross-peak to HO-2” (H 
5.29). Three-bond HMBC correlations linked both H-1” to a 
quaternary carbon signal (C 79.44) for C-3” linked to another 
oxygen. H-2” was linked by HMBC to two methyl signals (C-4” 
C 21.53 and C-5” C 25.61). Weak four-bond HMBC cross-
peaks from H-4” (H 1.32) and H-5” (H 1.24) to C-7 (C 159.3) 
confirmed the six-membered dihydropyran ring fused at C-7 
and C-8. NOESY cross-peaks showed that H-2” is close in space 
to both H-4” and H-5”; this is only possible if H-2” is in a 
pseudoequatorial position. This conformation was supported 
by the 1H NMR signals for both H-1” being broad doublets, 
with only the 2J value being large (>4 Hz); hence there were no 
pseudoaxial / pseudoaxial interactions with H-2” and it adop-
ted a pseudoequatorial conformation (Figure 2A). The geminal 
methyl groups in 2 resonated at different chemical shifts in 
both 1H and 13C spectra, which reflect their axial and equatorial 
positions in the pseudochair of the dihydropyran conformation 
(Figure 2A). This contrasted with the almost planar 
conformation of the dihydrofuran in 1, in which the CMe2 unit 
was exocyclic and the signals for the diastereotopic methyl 
groups were accidentally coincident in both 1H and 13C spectra. 
These spectroscopic data confirmed the structure of 2 
(retamasin D), a new compound. The CD spectrum 
(Supplementary Information) showed a positive peak in the 
region 260 nm – 400 nm; using the analysis of Wei et al.17 
suggests that 2 may have R configuration. 
The positive-ion HRESIMS of 3 showed an [M + H]+ peak at 
m/z 355.1159 (calcd 355.1181) for the molecular formula 
C20H18O6. The negative-ion spectrum contained ions at m/z 
353.1020 ([M – H]- calcd 353.1025), m/z 707.2126 ([2 M – H]- 
calcd 707.2129) and m/z 743.1894 ([2 M + 35Cl]- calcd 
Table 1. 1H and 13C NMR data for 1-3,5 in (CD3)2SO [H, multiplicity (J (Hz)); C, type] 
 1 2 3 5 
Position H C H C H C H C 
2  163.8, Cq  164.0, Cq  164.2, Cq 8.39, s 154.9, CH 
3 6.80, s 103.2, CH 6.82, s 103.5, CH 6.78, s 103.5, CH  122.8, Cq 
4  182.3, Cq  182.4, Cq  182.7, Cq  181.0, Cq 
4a  104.7, Cq  105.0, Cq  104.00, Cq  105.5, Cq 
5  161.8, Cq  159.3, Cq a  160.2, Cq  157.6, Cq b 
6 6.28, s 93.995, CH 6.13, s 99.5, CH 6.28, s 9.99, CH  109.8, Cq 
7  166.7, Cq  159.4, Cq a  161.8, Cq  160.2, Cq 
8  104.5, Cq  99.8, Cq  101.4, Cq 6.49, s 94.1, CH 
8a  152.2, Cq  154.8, Cq  155.5, Cq  157.7, Cq b 
1’  121.5, Cq  121.7, Cq  122.0, Cq  121.4, Cq 
2’,6’ 7.94, d, J 8.1 128.9, CH 7.92, d, J 8.8 128.8, CH 7.85, d, J 8.8 129.0, CH 7.39, d, J 8.4 130.6, CH 
3’,5’ 6.95, d, J 8.1 116.5, CH 6.93, d, J 8.8 116.5, CH 6.91, d, J 8.8 116.4, CH 6.83, d, J 8.4 115.6, CH 
4’  162.3, Cq  161.8, Cq  164.0, Cq  158.0, Cq b 
1” 3.29, m 26.5, CH2  2.73, dd, J 
16.1, 6.8; 
3.05 dd, J 
16.1, 5.2  
25.3, CH2  3.95, s 35.2, CH2 5.02, s 73.0, CH 
2” 4.80, dd, 
J 8.6, 8.1  
92.0, CH  3.75, brt, J 6 67.3, CH   211.5, Cq 4.17, d, J 3.8 73.9, CH 
3”  70.5, Cq   79.4, Cq  2.84, m ~40, CH  88.4, Cq 
4” 1.18, s  25.3, CH3  1.32, s  21.5, CH3 1.07, d, J 6.9 18.8, CH3 3.91, d, J 
10.3; 4.05, d, 
J 10.3 
77.0, CH2 
5” 1.18, s 26.2, CH3  1.24, s  25.6, CH3  1.07, d, J 6.9 18.8, CH3 1.50, s 16.4, CH3 
HO-5 13.19, s  12.70, s  12.96, s  13.37, s  
HO-7     10.7, br    
HO-3’   5.29, br      
HO-4’ 10.45, br  10.4, br  10.4, br  9.64, s  
HO-2”       5.90, d, J 3.8  
HO-3” 4.74, br         
 a Assignments could be reversed. b Assignments could be interchanged. 
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743.1895). The 13C NMR spectrum (Table 1) contained seven-
teen discrete signals, of which ten were for quaternary 
carbons, five for methine carbons, one for a methylene carbon 
and one for two magnetically equivalent methyl carbons. The 
carbonyl resonance at C 211.53 showed a dialkyl ketone. The 
IR spectrum showed absorbances for OH (3347 cm-1), a 
conjugated aryl ketone carbonyl (1654 cm-1) and a H-bonded 
dialkyl ketone carbonyl (1697 cm-1). 
Analysis of the 1H, 13C, COSY, HSQC and HMBC NMR spectra 
of 3 indicated a structure similar to that of apigenin (4′,5,7-
trihydroxyflavone). C-8 (C 101.38) was quaternary (no HSQC 
correlations), showing that the substituent was attached to the 
apigenin core at this position. Three phenolic OH signals were 
seen: HO-5 (H 12.96, s), HO-4’ (H 10.4, br) and HO-7 (H 10.7, 
br) H-bonded to the dialkyl ketone. The methylene protons (H-
1′′) resonated as a singlet (H 3.95), thus the compound is 
achiral. This signal showed three-bond HMBC cross-peaks to C-
7 (C 161.79) and C-8a (C 155.52) and a two-bond cross-peak 
to C-8 (C 101.38), confirming that CH2-1” is attached at C-8 of 
the flavone. A weaker two-bond HMBC correlation connected 
the dialkyl ketone signal C-2′′ (C 211.53) to H-1”. The presence 
of an isopropyl group was shown by a doublet, integrating for 
6 H, at H 1.07 (H-4” / H-5”) and a multiplet signal for H-3” at 
H 2.84. Three-bond HMBC cross-peaks were observed 
between the signals for H-4” / H-5” and the signal for the C-2” 
ketone. Thus 3 (retamasin E, a novel compound) is identified 
as a 8-prenylated apigenin oxidised to a ketone at C-2′′. 
Compound 4 was identified as licoflavone C by comparison 
of the NMR spectra (Table S1, ESI) and melting point with the 
data reported for synthetic and natural product samples.18,19 It 
should be noted that the NMR data should be compared with 
compound 10 in Al-Maharik and Botting19 and not compound 
6, as the spectroscopic data for these two compounds were 
erroneously transposed in that paper. IR data were also 
consistent with the structure. 
The positive-ion HRESIMS of 5 showed that the molecular 
formula is C20H16O7, with [M + H]+ observed at m/z 369.0953 
(calcd 369.0974), [M + Na]+ m/z 391.0772 (calcd 391.0794), [2 
M + H]+ m/z 737.1833 (calcd 737.1870) and [2 M + Na]+ m/z 
759.1652 (calcd 759.1690). This was confirmed by negative-ion 
HRMS peaks at m/z 367.0818 [M – H]- (calcd 367.0818), m/z 
403.0585 [M + 35Cl]- (calcd 403.0585), m/z 413.0874 [M + 
HCO2]- (calcd 413.0873), m/z 771.1491 [2 M + 35Cl]- (calcted 
771.1481) and m/z 781.1791 [2 M + HCO2]- (calcd 781.1769). 
Compound 5 was an isoflavone, as shown by the downfield 
chemical shift of the 1H NMR singlet for H-2 (H 8.39) (Table 1), 
which had HSQC connectivity with C-2 (C 154.93). This proton 
showed a strong HMBC cross-peak with the signal for the 
carbonyl C-4 (C 180.96) and a weaker two-bond correlation 
with quaternary C-3 (C 122.85) but not with C-4a (C 105.51). 
The latter was clearly identified by its HMBC correlation with 
H-8 (H 6.49). H-8 made a two-bond correlation with C-8a (C 
157.63 / 157.66 / 158.02), which formed a three-bond 
connection with H-2. The 4-hydroxyphenyl unit at C-3 was 
demonstrated by HMBC correlations from H-2’ / H-6’ (H 7.39) 
to C-3 (C 122.85) and from H-2 to C-1’ (C 121.41). HO-4’ (H 
9.64) was identified by a HMBC cross-peak with C-3’ / C-5’ (C 
115.56). In the IR spectrum, peaks were seen for the OH (3333 
cm-1) and conjugated aryl ketone (1643 cm-1) groups. C-6 (C 
109.85) was quaternary and the chemical shift indicated 
substitution with a sp3-hybridised carbon. It made a three-
bond correlation with H-8 and a good two-bond correlation 
with H-1” (H 5.02). C-1” was a methine, with the 13C NMR 
signal at C 73.03. H-1” also showed a two-bond HMBC 
correlation with C-2′′ (C 73.90) and three-bond correlations 
with C-3” (C 88.38) and C-4” (C 77.01). Of these, C-3” was 
quaternary, C-2” was a methine and C-4” was a methylene; the 
chemical shifts of each indicated an attached oxygen. Both of 
the diastereotopic H-4” protons formed HMBC cross-peaks 
with C-1” and C-2” through three bonds, but only the signal at 
H 3.91 formed a cross-peak with the methyl signal at C 16.39 
(C-5”). The lack of cross-peak from H 4.05 was likely to be due 
to the dihedral angle along (C-3”)–(C-4”) between the (C-4”)–H 
bond to this proton and the (C-3”)–(C-5”) bond being ca. 90. 
Thus the diastereotopic H-4” 1H NMR signals were tentatively 
assigned as shown in Figure 2B. A similar argument can be 
used to suggest that HO-2′′ may be located in the exo position 
(Figure 2B), as the dihedral angle between the (H-2”)–(C-2”) 
bond and the (C-3”)–(C-5”) bond was also ca. 90 in this 
diastereoisomer, whereas it was ca. 30 in the other (HO-2′′ 
endo) structure. Further evidence was provided by H-2” being 
coupled only to HO-2” and not to H-1” and the lack of a 
corresponding COSY cross-peak; this was only possible when 
HO-2′′ was located exo and the dihedral angle between (H-1”)–
(C-1”) and (H-2”)–(C-2”) is ca. 90. The HO-2”-exo diastereo-
isomer was confirmed by the observation of a strong NOESY 
cross-peak from the HO-2” (H 5.90) to the H-4” signal (H 4.05) 
and a weaker one to H-4” (H 3.91). This observation also 
assigned the signals for the diastereotopic H-4”, with H-4” (H 
4.05) being on the face towards the OH. The methyl group (5”) 
was located as being attached at C-3”, as it was a singlet and 
through a two-bond HMBC cross-peak from H-5” (H 1.50) to 
C-3” and a weak four-bond cross-peak to C-7 (C 160.19). 
Taken together, these correlations demonstrated that there is 
a bicycle fused to the flavone core at C-6 and C-7 and that the 
structure of 5 (retamasin F, a novel compound) was as shown. 
From the positive value in the 260 nm – 400 nm region of the 
CD spectrum (Supplementary Information), we tentatively 
assign the configuration of 5 as 1”S, 2”S, 3”R.17 
In positive-ion mode, HRESIMS of 6 showed a peak for [M + 
H]+ was seen at m/z 369.0970 (calcd 369.0974), corresponding 
to the molecular formula C20H16O7. Supporting this assignment 
were peaks for [M + Na]+ at m/z 391.0772 (calcd 391.0794), [2 
M + H]+ at m/z 737.1832 (calcd 737.1870) and [2 M + Na]+ at 
m/z 759.1651 (calcd 759.1690). Negative ions were observed 
for [M + 35Cl]- at m/z 403.0585 (calcd 403.0585), [M + HCO2]- at 
m/z 413.0873 (calcd 413.0873) and [2 M + 35Cl]- m/z 771.1478 
(calcd 771.1481). It is an isomer of 5. The 13C NMR spectrum 
(Table 2) showed eighteen discrete resonances, of which two 
were each for two carbons in magnetically equivalent 
environments. There were signals for ten quaternary carbons 
(including one carbonyl), eight methine carbons, one 
methylene carbon and one methyl carbon. 
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As for 5, this compound gave NMR resonances character-
istic of an isoflavone substituted at C-6 (C 109.10) with a sp3-C 
substituent. C-2 was a methine and resonated downfield at C 
154.86. The H-2 signal was also downfield (H 8.38) and was 
identified by HMBC cross-peaks to C-1’ (C 121.38), C-4 (C 
181.30) and C-8a (C 159.86). The 3-(4-hydroxyphenyl) unit 
was also located with a strong HMBC correlation from H-2’ / H-
6’ (H 7.36) to C-3 (C 122.76). C-8 (C 89.44) is a methine and 
H-8 (H 6.59) formed two-bond HMBC correlations with C-7 (C 
167.38) and C-8a (C 159.86) and three-bond correlations with 
C-4a (C 106.22) and C-6 (C 109.10). Two phenolic OH signals 
were present in the 1H NMR spectrum, H-4’ at H 9.58 and the 
intramolecularly H-bonded HO-5 at H 13.47. One aliphatic OH 
signal was observed at H 5.30, which was shown by HSQC to 
be a tertiary alcohol attached at C-3” (C 77.08). The IR 
spectrum contained peaks for the OH (3363 cm-1) and 
conjugated aryl ketone (1655 cm-1) groups, consistent with a 
hydroxylated isoflavone. Attached to C-6 was a methine 
carbon C-1” (C 78.68), with H-1” forming an HMBC cross-peak 
with C-7 (C 167.38). This carbon comprised one atom of a 
tetrahydrofuran, which was demonstrated as follows. H-1” 
correlated with C-4” (C 72.79) in the HMBC spectrum and one 
of the methylene protons H-4” (H 3.45) correlates back with 
C-1”, joining the bridge across the oxygen. This H-4” also 
formed a three-bond correlation with C-2” (C 91.91) and H-2” 
(H 4.76) showed a cross-peak with C-4”. The final carbon of 
the tetrahydrofuran, quaternary C-3”, was identified through 
two-bond HMBC correlations with both H-4” methylene 
protons (H 3.18 and H 3.45) and with H-2”. The substituents 
at C-3” were an alcohol (as noted above) and a methyl group. 
C-5” (C 25.12) of the methyl group correlated in HMBC with 
both H-4” methylene protons, with HO-3” and with H-2”, 
whereas the H-5” protons formed cross-peaks with C-2’, C-4” 
and, more weakly, with C-3”. As C-2” was a methine and there 
were only two phenolic OH signals, then C-2” must be 
attached to the oxygen at C-7 of the isoflavone core and the 
6,7-substitution must be a tetrahydrofuranofuran. Thus 6 
(retamasin G) had the new structure shown. 
 This structure has three chiral centres and thus four dia-
stereoisomers were possible. NOESY cross-peaks between H-
1” and H-2” confirmed that the tetrahydrofuran / dihydrofuran 
ring-fusion in 6 had cis configuration (Figure 2C). The coupling 
constant between these two protons 3J1”-2”was 5.6 Hz, which is 
close to the corresponding 3Jcis in the tetrahydrofuran / 
dihydrofuran fused system in panacene20 (6.0 Hz) and in a 
related cis-3a,8b-dihydrofuro[3,2-b]-benzofuran-2(3H)-one 
(5.8 Hz).21 Correlation was also seen in the NOESY spectrum 
between H-2” and H-5”, which shows that this methyl is also 
cis to H-2”. The diastereotopic methylene proton signals were 
assigned by NOESY correlations HO-3”→H-4” (H 3.18) and H-
5”→H-4” (H 3.45), as shown in Figure 2C. 
The benzo-fused furanofuran unit in 6 is hitherto unknown 
in natural-product flavones and isoflavones, although it is pres-
ent in the hexahydrofuranobenzofurans (+)-panacene (from 
the sea hare Aplysia brasiliana),22 platypodantherone (from 
Platypodanthera melissaefolia),23 and (+)-gynunone (from 
Gynura elliptica).24 The motif is seen fused to coumarin in 
compounds from Aegle marmelos25 and Peucedanum praerup-
torum,26 and to xanthones in psorofebrin and related comp-
ounds from Psorospermum febrifugum.27 In all cases, the two 
furans are cis-fused, as in 6. However, amongst compounds 
with Me and OH at the equivalent of C-3′′, two examples have 
the same relative configuration as 6 (with Me cis to the ring-
junction-H).25,26 Two others have the opposite configuration 
(Me trans to ring-junction-H), although one lacks the OH.24,27 
The positive-ion HRESIMS of 7 contained a peak for [M + 
H]+ m/z 367.0800 (calcd 367.0818), corresponding to the 
molecular formula C20H14O7. A peak for [2 M + Na]+ was seen 
at m/z 755.1344 (calcd 755.1377). The negative-ion spectrum 
contained peaks at m/z 365.0659 ([M – H]-, calcd 365.0661), 
m/z 731.1399 ([2 M – H]-, calcd 731.1401) and m/z 767.1164 
([2 M + 35Cl]-, calcd 767.1168). The 13C NMR spectrum (Table 2) 
contained eighteen discrete resonances, with two of the 
methine signals representing two equivalent carbons each. 
There were signals for eleven quaternary carbons, eight 
methine carbons and one methyl carbon. The 1H spectrum 
contained signals for three phenolic OH groups, HO-4′ (H 
9.65), H-5 (H 13.73) and HO-7 (H 11.5). 
Compound 7 was an isoflavone, with the singlet for H-2 at 
H 8.37, the methine carbon C-2 at C 154.70 and the 
quaternary C-3 at C 122.97. The 3-(4-hydroxyphenyl) substit-
uent was shown by signals at H 7.40 (H-2’ / H-6’) and H 6.84 
(H-3’ / H-5’). The former correlated in the HMBC spectrum 
with C-4’ (C 157.72 or 158.00) and with C-3. An HMBC cross-
peak from H-3’ / H-5’ identified C-1’ (C 121.44). IR peaks were 
observed for the OH (3322 cm-1) and conjugated aryl ketone 
(1630 cm-1) groups, consistent with a hydroxylated isoflavone. 
H-8 (H 6.46) showed HMBC cross-peaks with C-4a (C 104.11 
or 104.40), 6-C (C 104.11 or 104.40), C-7 (C 167.59) and C-8a 
(C 161.73) and weakly with C-2 through four bonds. The 1H 
NMR signal at H 6.36 was identified as being attached to sp3-
hybridised C-1′′ (C 74.16) and hence to C-6 by HMBC cross-
peaks to C-5 (C 157.72 or 158.00), C-6 and C-7. The unusually 
downfield chemical shift of this proton was consistent with its 
benzylic environment, with lactone oxygen and alkene groups 
adjacent. A strong two-bond HMBC cross-peak of H-1” to C-2” 
(C 149.15) identified the alkene and the downfield chemical 
shift of the C-2” signal indicated that the alkene was conjug-
ated to a carbonyl. A weak three-bond cross-peak was seen 
between H-1” and alkene carbon C-3” (C 128.48). H-2” (H 
7.35) correlated in HMBC with the lactone carbonyl C-4” (C 
175.03). Finally, the methyl-5” was located as being attached 
to the lactone at C-3” by HMBC correlations from H-5” to C-3”, 
C-4” and C-2”. Thus the structure of 7 (retamasin H) was con-
firmed as a novel isoflavone carrying a -lactone substituent at 
C-6. 
Compound 8 gave a [M + H]+ peak in the HRESIMS at m/z 
395.1473 (calcd 395.1495), corresponding to the molecular 
formula C23H22O6. A further peak was seen for [2 M + H]+ at 
m/z 789.2872 (calcd 789.2911). The negative-ion HRMS confir-
med the formula with a plethora of peaks for [M – H]- at m/z 
393.1340 (calculated 393.1338), [M + 35Cl]- at m/z 429.1105 
(calcd 429.1105), [M + HCO2]- m/z at 439.1394 (calculated 
439.1393), [2 M – H]- at m/z 787.2752 (calcd 787.2755), [2 M + 
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35Cl]- at m/z 823.2519 (calcd 823.2518) and [2 M + HCO2]- at 
m/z 833.2807 (calculated 833.2809). Twenty-one discrete 13C 
NMR signals were recorded (Table 2), with two resonances 
corresponding to two equivalent carbons each. Ten signals 
were for quaternary carbons (all sp2); there were nine 
methines (eight sp2, one sp3), two methylenes and two 
methyls. In the IR spectrum, peaks were seen for OH (3311 
cm-1) and aryl ketone (1630 cm-1), consistent with a hydroxyl-
ated isoflavone. 
The core of 8 was an isoflavone, with NMR signals for H-2 
at H 8.37 and for methine C-2 at C 154.73. The singlet signal 
for H-8 (H 6.50) correlated in the HMBC spectrum with C-4a 
(C 105.76), C-6 (C 105.02), C-7 (C 159.72) and C-8a (C 
157.96), with a weaker four-bond cross-peak with the carbonyl 
C-4 (C 180.91). 1H NMR signals for two phenols were 
recorded: HO-4’ (H 9.62) and H-5 (H 13.38); thus the oxygen 
at the 7-position must be substituted. C-6 was shown to be 
quaternary, so a ring system connecting C-6 and O-7 was 
expected. H-1” (H 6.66) resonated as a broad doublet, 
coupled to H-2” (H 5.74, 0.5 H; H 5.75, 0.5 H), as confirmed 
by a cross-peak in the COSY spectrum. Both protons formed 
cross-peaks in the HMBC spectrum with C-3” (C 81.10). 
Moving outwards in the substituent, C-3” formed two-bond 
HMBC cross-peaks with both diastereotopic protons of the 
CH2-4” methylene (H 1.65 m and H 1.80 m; C 36.95); another 
cross-peak linked C-4” with H-2”. Strong COSY cross-peaks 
showed that this methylene was adjacent to another 
methylene, with both H-6” protons resonating as a complex 
multiplet (H 1.4) and the signal for C-6” appearing at C 33.66. 
Further COSY correlation showed that H-6’ is coupled to a 
methine proton (H-7”) at H 3.56. This chemical shift, together 
with the chemical shift for C-7” (C 66.23), suggested an 
electronegative substituent here. Correspondingly, HO-7” (H 
4.41) resonated as a doublet (J 2.9 Hz), with a COSY connection 
to H-7” and with HMBC connections to C-6”, C-7” and a methyl 
(C-8”; C 24.17). The structure of this side-chain was tied 
together through further HMBC cross-peaks H-7”C-4” and H-
8”C-6”. The remaining methyl carbon was identified as C-5” 
(C 27.40) through HMBC correlations with H-2”; both H-4” 
and H-5” correlated with C-3”. Thus 8 (retamasin I) had the 
Table 2. 1H and 13C NMR data for 6-8 in (CD3)2SO [H, multiplicity (J (Hz)); C, type] 
 6 7 8 
Position H C H C H C 
2 8.38, s 154.9, CH 8.37, s 154.7, CH 8.37, s 154.7, CH 
3  122.8, Cq  123.0, Cq  122.9, Cq 
4  181.3, Cq  181.0, Cq  180.9, Cq 
4a  106.2, Cq  104.1, Cq a  105.8, Cq 
5  158.9, Cq  157.7, Cq b  157.2, Cq 
6  109.1, Cq  104.4, Cq a  105.0, Cq 
7  167.4, Cq  167.6, Cq  159.7, Cq 
8 6.59, s 89.4, CH 6.46, s 93.9, CH 6.50, s 94.8, CH 
8a  159.9, Cq  161.7, Cq  158.0, Cq 
1’  121.4, Cq 6.36, br 74.2, CH  121.5, Cq 
2’,6’ 7.36, d, J 8.5 130.7, CH 7.40, br 130.7, Cq 7.39, d, J 8.3 130.6, CH 
3’,5’ 6.81, d, J 8.5 115.6, CH 6.84, br 115.6, Cq 6.83, d, J 8.3 115.4, CH c 
4’  158.0, Cq  158.0, Cq b  156.4, Cq 
1” 5.71, d, J 5.6 78.7, CH 5.71, d, J 5.6 78.7, CH 6.66, brd, J 10.3 115.5, CH c 
2” 4.76, d, J 5.6 91.9, CH 7.35, br 149.1, CH  5.74, 0.5 H, d, J 10.1; 
5.75, 0.5 H, d, J 10.1 
128.6, CH 
3”  77.1, Cq   128.5, Cq   81.1, Cq  
4” 3.18, d, J 8.5 
3.45, d, J 8.5  
72.8, CH2   175.0, Cq  1.62, 0.5 H, m; 1.67,  
0.5 H, m; 1.81, 0.5 H, 
m; 1.87, 0.5 H, m  
36.9, CH2  
5” 1.29, s  25.1, CH3  1.87, s  10.8, CH3  1.41, s  27.4, CH3  
6”     1.4, m  33.7, CH2  
7”     3.56, septet, J 6.0 66.2, CH  
8”     1.03, d, J 6.0  24.2, CH3  
HO-5 13.47, s  13.73, s  13.38,s  
HO-7   11.5, br    
HO-4′ 9.58, br  9.65, br  9.62, s  
       
HO-3” 5.30, br       
HO-7”     4.407, 0.5.H, d, J  4.4; 
4.414, 0.5 H, d, J 4.4  
 
a Assignments could be reversed. b Assignments could be reversed. c Assignments could be reversed.  
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structure shown. The detail of the 1H and COSY NMR spectra 
showed that there were two overlapping signals for each of H-
2”, H-6” and HO-7”, each integrating for 0.5 H. This may 
indicate that the novel compound 8 had been isolated as an 
equimolar mixture of diastereoisomers. Figure 2D shows an 
overlay of the MM2-minimised structures of these 
diastereoisomers and reveals that the environments of these 
protons were the most significantly different between these 
forms. The positive value in the 260 nm – 400 nm region of the 
CD spectrum (Supplementary Information) suggests that the 
configuration of 8 may be 3”S,17 with a 50:50 mixture of 
epimers at C-7”.  
Compounds 9 and 10 were identified as erysubin B and 
erysubin A, respectively. Their 1H and 13C NMR spectra (Table 
S1, ESI) were almost identical to those reported for 
compounds isolated from the wood of Erythrina suberosa var. 
glabrescens.28 The assignments were supported by COSY, 
HSQC and HMBC data and by comparison of mp with literature 
values. 
C-Prenylation of flavones is well known in plants, although 
a review by Botta et al. suggested that C-prenylated iso-
flavones were less common, as isoflavone synthase and 
prenyltransferases were less widespread in nature.29 The C-
prenyl group is also found cyclised onto an ortho-phenol to 
form extensive ranges of furanoflavones and pyranoflavones.30 
One may speculate that the isomeric furanoflavone 1 and 
pyranoflavone 2 (also atalantoflavone16) arise through 5-exo 
and 6-endo cyclisations of a common oxidised derivative of 4, 
such as 8-(3,3-dimethyloxiranylmethyl)-4′,5,7-trihydroxyflav-
one. Retamasin A and retamasin B, previously reported in R. 
raetam,16 are furanoflavones which may also derive from 4. 
In the isoflavone series, 5, 6, 7, 9 and 10 can all be 
identified as derivatives of a 6-prenylated isoflavone which 
have been oxidised and cyclised in different modes. The 6-
prenyl unit can also be identified as C-1”, C-2”, C-3”, C-4” and 
C-5” in 8 but a three-carbon extension (C-6”, C-7” and C-8”) is 
also present. The biosynthetic origin of these three carbons is 
unclear but they may be the stump of another prenyl unit 
which has been partly trimmed down. The benzo-fused bicyclic 
system in 5 is new amongst natural products but has been 
identified synthetically as the product of treatment of 2-(1-
hydroxy-2-methyl-2-(oxiran-2-yl)ethyl)phenols (oxiranes 
derived from an arylisoprene) with acid at low temperature.31 
More vigorous treatment with acid triggers an elimination 
reaction to give 2-hydroxymethylchromenes. It may be that 5 
is biosynthesised from a 6-prenylisoflavone and subsequently 
undergoes acid-catalysed elimination to give 9. 
Type-2 diabetes is a long-term metabolic disease in which 
the ability of peripheral cells to take up glucose from the blood 
in response to insulin is decreased (“insulin resistance”), lead-
ing to an increase in the concentration of glucose in the blood 
and thence to a range of pathologies. There is also some loss 
of glucose-stimulated release of insulin by the -cells of the 
Islets of Langerhans in the pancreas. Clinically used drugs for 
treatment of this disorder mostly address either the produc-
tion of insulin by the -cells (sulfonylureas, e.g. tolbutamide, 
glibenclamide) or increase the sensitivity of the peripheral cells 
to insulin (stimulating uptake of glucose, e.g. metformin). 
Type-1 diabetes also involves loss of glucose-stimulated rel-
ease of insulin by the -cells. Thus the flavonoids 1-10 isolated 
from R. raetam were evaluated for their ability to increase the 
secretion of insulin by isolated murine pancreatic islets.  
Figure 3 shows the amount of insulin secreted per islet in 
the presence of the compounds (200 M), with tolbutamide 
(200 M, positive control) and in the absence of test 
compound (negative control). The insulin secretory activity of 
control islets was 8.5 ± 0.38 ng islet-1 h-1 upon stimulation by 
glucose (16.7 mM). This secretion was enhanced significantly 
(p<0.01) in the presence of the standard sulfonylurea drug 
tolbutamide (19.49 ± 1.69 ng islet-1 h-1). Isoflavone 7 had little 
effect and flavones 2 and 4 inhibited the release of insulin 
under these conditions. However, the remaining flavonoids 
stimulated the glucose-triggered release of insulin significantly, 
with 8 and 9 raising the production of insulin ca. 3-fold and 
1,3,5,6,10 raising secretion by ca. 5-fold. There is no clear 
prima facie structure-activity relationship distinguishing potent 
stimulators from weaker stimulators or inhibitors and the 
biochemical target is unknown but these flavones / isoflavones 
represent interesting new lead structures for further develop-
ment of drugs to treat Type-2 diabetes and may explain the 
traditional use of this plant.4 
Inhibitors of -glucosidase, a key enzyme in the digestion 
of polysaccharides, are also used in the management of 
diabetes. These inhibitors have diverse structures. Acarbose, a 
mimic of a tetrasaccharide, is particularly effective in populat-
ions with a diet high in carbohydrate.32 2-(3-Ethoxy-4-hydroxy-
phenyl)quinazolin-4-one was the most potent inhibitor of -
glucosidase amongst a series of quinazolinones33 and the 
natural product sarcoviolin  is potently inhibitory.34 Table 3 
lists the percentage inhibition of -glucosidase activity by flav-
onoids 1,2,5-7,9,10 at 50 M; acarbose was used as a positive 
control. All test compounds showed some activity. The most 
potent flavonoid 7 showed IC50 = 36.3 ± 1.7 M for inhibition 
of this enzyme. 
Conclusions 
This paper reports major extension of the number of flavon-
oids isolated and characterised from R. raetam. Three new 8-
Table 3. Percentage inhibition of the activity of -glucosidase 
by flavonoids isolated from R. raetam. 
Compound % Inhibition of -glucosidase activity 
at 50 M 
1 62.9  1.9 
2 43.6  0.4 
5 33.2  1.6 
6 61.0  0.6 
7 96.3  0.2 
9 46.7  0.9 
10 67.9  0.7 
Acarbose (positive 
control) 
98.7  0.9 
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prenylated flavone derivatives 1-3 and four new 6-prenylated 
isoflavone derivatives 5-8 are reported, along with identific-
ation of two known isoflavones 9,10 newly observed in this 
plant. The fused bicyclic heterocycles in 5 and 6 are demonst-
rated in naturally occurring flavonoids for the first time. 
Although only modest activity was seen in many of the new 
flavonoids in inhibition of the catalytic activity of -glucosid-
ase, 7 showed similar potency to acarbose and may be worthy 
of further investigation. More importantly, five of the new 
flavonoids (1,3,5,6,10) showed strong stimulation of the 
glucose-triggered release of insulin from pancreatic islets, with 
effects much greater than that of the widely used antidiabetic 
drug tolbutamide. Although they are isomers, 1 and 2 showed 
very different activities in the insulin secretion assay (Figure 3); 
this reflects the very different conformations of the saturated 
heterocycles and the presentation of the functional groups to 
the receptor(s). These biological observations rationalise the 
traditional use of R. raetam in folk medicine and provides new 
structural leads for drugs development for treatment of this 
rapidly increasing major worldwide disease, adding to the 
range of therapeutic activities known for prenylated 
flavonoids.35 
Experimental 
General experimental procedures 
IR spectra were recorded on a Perkin-Elmer FTIR 600 series 
spectrometer. UV spectra were obtained from an HP 8453 
diode array spectrophotometer. The 1D and 2D NMR (COSY, 
HSQC, HMBC) spectra using standard pulse programs were 
recorded at room temperature on a Bruker Avance DRX 700 
spectrometer operating at 700 MHz (1H) and 175 MHz (13C), on 
a Bruker Avance 500 FT spectrometer at 500 MHz (1H) and 125 
MHz (13C), and on an Agilent 400 spectrometer at 400 MHz 
(1H) and 100 MHz (13C). Chemical shifts ( are reported in 
parts per million (ppm) relative to the internal standard SiMe4 
and coupling constants (J) are given in in Hz. HRESIMS were 
obtained on an Agilent Series 1100 SL mass spectrometer. 
Column chromatography was performed using normal-phase 
silica gel (Merck; 230-400 m) and reversed-phase silica gel 
(LiChroprep RP-18, Merck; 40-63 m). Preparative HPLC was 
performed on a Shimadzu system (Kyoto, Japan), consisting of 
two LC-6AD Semi-Preparative Solvent Delivery pumps 
connected with Rheodyne manual injector, communications 
bus module CBM-20A, a multi-wavelength photo-diode array 
detector (SPD-M20A), FRC-10A fraction collector, and 
Shimadzu LC solution software. The column was a Shim-pack 
PREP-ODS(H) Kit 250 mm × 20 mm, with 5 m particles. The 
gradient elution used a mobile phase consisting of acetonitrile 
and water (2:3) programmed linearly to 100% MeCN over 25 
min at the flow rate 20 mL min-1. The UV detection wavelength 
was 254 nm. Analytical HPLC was performed using the same 
system but with a Shim-pack PREP-ODS(H) Kit (A) 250 mm × 
4.6 mm with 5 m particles and flow rate 1.0 mL min-1. TLC 
was carried out on silica gel sheets (Alugram Sil G/UV254, 
Macherey-Nagel, Germany) and reversed-phase plates (RP-18 
F254S, Merck, Germany), with visualisation by 10% aq. H2SO4, 
followed by heating. 
Plant material 
The aerial parts of Retama raetam were collected in April 2010 
near Al-looz Mountain, Tabook, Saudi Arabia and were 
identified by Dr. M. Yusuf, taxonomist, College of Pharmacy, 
King Saud University (KSU), Riyadh, Saudi Arabia. A voucher 
specimen (No.15567) has been deposited at the herbarium of 
the College of Pharmacy, KSU. 
Extraction and isolation 
The air-dried aerial parts (1.0 Kg) of Retama raetam were per-
colated at room temperature with CHCl3 and the solvent was 
evaporated to yield a dark brown residue (30.0 g). This extract 
was partitioned between hexane and MeCN to afford hexane 
fraction (10.0 g) and MeCN fraction (14.0 g). The MeCN 
fraction (13.0 g) was subjected to silica gel chromatography 
(5.5 × 50 cm) with a linear gradient elution of methanol and 
CHCl3 to give fractions A–T. Fraction D (150 mg) was separated 
by reversed-phase silica gel column chromatography (MeOH / 
H2O, 4:1  MeOH) to give 1 (8.0 mg), 2 (5.0 mg) and 3 (2.1 
mg). Fraction E (414 mg) was separated by reversed-phase 
chromatography on a C18 column (MeCN / H2O, 13:7  MeCN) 
to yield 4 (2.7 mg), 5 (4.1 mg) and 6 (1.2 mg), Fraction F (495 
mg) was separated by reversed-phase silica gel column 
chromatography (MeOH / H2O, 3:1  MeOH) to give 7 (4.1 
mg), 8 (2.1 mg) and 9 (4.0 mg). Fraction H (241 mg) was 
further purified by reversed-phase chromatography on a C18 
column (MeOH / H2O, 7:3  MeOH) to yield 10 (0.8 mg). 
Retamasin C (1): yellow powder; mp 195-196C; []25D 
−18.6 (c 0.7, MeOH); UV (MeOH) max (log 311 (3.68), 263 
(3.62) nm; IR (KBr) max 3315, 1650, 1601, 1589, 1511 cm-1; 1H 
and 13C NMR data, see Table 1; HRESIMS: m/z 355.1156 [M + 
H]+ (calcd for C20H19O6, 355.1181). 
Retamasin D (2): yellow powder; mp 204-206C; []25D 
−10.9 (c 0.11, MeOH); UV (MeOH) max (log 324 (3.60), 263 
Figure 3. Glucose-stimulated secretion of insulin from murine 
pancreatic islets by compounds 1-10. Freshly isolated islets were 
incubated for 1 h at 37C in KRB buffer containing glucose (16.7 
mM) in the absence (negative control) or presence of different test 
compounds and the amount of insulin secreted was measured. 
Values are mean ± SEM from three independent experiments. **P 
< 0.01, ***P < 0.001, compared with the value for the negative 
control. TB = tolbutamide. 
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(3.54) nm; IR (KBr) max 3341, 1645, 1544, 1473 cm-1; 1H and 
13C NMR data, see Table 1; HRESIMS: m/z 355.1161 [M + H]+ 
(calcd for C20H19O6, 355.1181). 
Retamasin E (3): yellow powder; mp 231-232C; UV 
(MeOH) max (log 333 (3.62), 263 (3.52) nm; IR (KBr) max 
3347, 1697, 1654, 1416 cm-1; 1H and 13C NMR data, see Table 
1; HRESIMS: m/z 355.1159 [M + H]+ (calcd for C20H19O6, 
355.1181). 
Licoflavone C (4): powder; mp 172-174C (lit.19 mp 173-
174C); UV (MeOH) max (log 326 ( 3.62), 305 (3.56) nm; IR 
(KBr) max 3267, 1651, 1423 cm-1; 1H and 13C NMR data, see 
Supplementary Information. 
Retamasin F (5): yellow powder; mp 224-225C; []25D 
−22.6 (c 0.7, MeOH); UV (MeOH) max (log 315 (3.64), 263 
(3.63); IR (KBr) max: 3333, 1643, 1608, 1574, 1521 cm-1; 1H and 
13C NMR data, see Table 2; HRESIMS: m/z 369.0953 [M + H]+ 
(calcd for C20H17O7, 369.0974). 
Retamasin G (6): yellow powder; mp 233-234C; []25D 
−26.0 (c 0.08, MeOH); UV (MeOH) max (log 333 (3.61), 263 
(3.55) nm; IR (KBr) max 3363, 1655, 1530, 1425 cm-1; 1H and 
13C NMR data, see Table 2; HRESIMS: m/z 369.0970 [M + H]+ 
(calcd for C20H17O7, 369.0974). 
Retamasin H (7): yellow powder; mp 247-248C; []25D 
−41.8 (c 0.23, MeOH); UV (MeOH) max (log 321 (3.62), 263 
(3.52); IR (KBr) max 3322, 1630, 1525, 1412 cm-1; 1H and 13C 
NMR data, see Table 2; HRESIMS: m/z 367.0800 [M + H]+ (calcd 
for C20H15O7, 367.0818). 
Retamasin I (8): yellow powder; mp 218-219C; []25D −2.8 
(c 0.10, MeOH); UV (MeOH) max (log 325 (3.62), 263 (3.52) 
nm; IR (KBr) max 3311, 1621, 1534, 1433 cm-1; 1H and 13C NMR 
data, see Table 2; HRESIMS: m/z 395.1473 [M + H]+ (calcd for 
C23H23O6, 395.1495). 
Erysubin B (9): powder; mp 248-249C (lit.32 mp 247-
249C); []25D −17.0 (c 0.10, MeOH); UV (MeOH) max (log 
284 (3.56), 225 (3.62); 205 (3.65) nm; IR (KBr) max 3342, 
1621, 1427 cm-1; 1H and 13C NMR data, see Supplementary 
Information. 
Erysubin A (10): powder; mp 231-232C (lit.32 mp 231-
233); UV (MeOH) max (log 353 (3.62), 267 (3.60); 212 (3.57) 
nm; IR (KBr) max 3355, 1598, 1419 cm-1; 1H and 13C NMR data, 
see Supplementary Information. 
Sources of materials for biological assays 
Tolbutamide (TB), collagenase V and bovine serum albumin 
(BSA) were obtained from Sigma (St. Louis, MO, USA). Mouse 
Ultrasensitive Insulin ELISA kit was purchased from Crystal 
Chem Inc. (IL, USA). 
Isolation of pancreatic islets 
Primary pancreatic islets were isolated from male BALB/c mice 
(28-36 g) from the International Center for Chemical and 
Biological Sciences (ICCBS) Animal Research Facility, University 
of Karachi, Pakistan. The handling of animals and harvesting of 
tissues were carried out in accordance with the National 
Institutes of Health guide for the care and use of Laboratory 
animals (NIH Publications No. 8023, revised 1978) and with 
prior approval from the Animal Use Committee of ICCBS 
(Protocol number: 2015-0020). Pancreatic islets were isolated 
by digestion with collagenase V and islet-picking methods as 
described earlier.36 Briefly, mice were anaesthetised with 
sodium thiopental (30 mg Kg-1) and the distended whole 
pancreas was digested at 37C in collagenase solution (1.0 mg 
mL-1) for 15 min. The digested islets were further purified by 
centrifugation at 1000 rpm for 1.0 min, followed by filtration 
using a pre-wetted 70 m cell strainer. Finally, the islets were 
manually picked with a siliconised Pasteur pipette under a 
NIKON SMZ-745 stereomicroscope. The isolation and purif-
ication medium used was Hank’s Balanced Salt Solution (HBSS) 
without calcium, magnesium and phenol red. Diameters were 
measured using a camera mounted on a stereomicroscope. 
Insulin secretion assay 
Freshly isolated islets (n = 3) of similar diameter (120−160 
m) were pre-incubated for 45 min at 37C in Krebs–Ringer 
bicarbonate (KRB) buffer solution containing BSA (0.1%) and 
glucose (3.0 mM) in Eppendorf tubes. Each was performed in 
triplicate. The islets were washed with KRB buffer before being 
transferred into KRB buffer (300 L) containing glucose (16.7 
mM), supplemented with either test compound (pre-dissolved 
in DMSO, 200 M) or tolbutamide (pre-dissolved in DMSO, 200 
M; a standard insulin secretagogue used as a positive control) 
and were incubated at 37C for 1.0 h. At the end of incubation, 
an aliquot (200 L) was placed on ice-cold water and kept at -
40C until the insulin was assayed. Concentrations of insulin in 
the collected aliquots were measured using the mouse 
ultrasensitive insulin ELISA kit according to the high-range 
protocol. The reading is the concentration of insulin in ng mL-1 
of medium. After calculation of the absolute amount of insulin 
in the medium, this amount was divided by three (the number 
of islets in the tube). 
Assay of inhibition of -glucosidase 
The assays of inhibition of -glucosidase were conducted 
according to the method reported elsewhere33 with slight 
modification. The reaction mixture contained sodium phos-
phate buffer (50 mM, pH 6.8) in a total volume of 300 L. -
Glucosidase (40 mU) from Saccharomyces cerevisiae (Sigma 
Chemical Co., St. Louis, MO, USA) was incubated with target 
compounds for 15 min at 37C. Compounds were dissolved in 
DMSO; the final concentration of this solvent in the assay 
mixture was 3%. After addition of 4-nitrophenyl--D-gluco-
pyranoside (0.7 mM), the enzyme reaction was continuously 
monitored at 400 nm in 96-well microplates using SpectraMax 
Plus 384 microplate reader (Molecular Devices, CA, USA). 
Acarbose was used as a positive control. The activity of the 
compounds was measured as percent inhibition of -glucos-
idase activity relative to controls with no test compounds. The 
assays were performed in quadruplicate and the mean 
percentage inhibitions were calculated, along with their 
respective SEM (standard error of the mean) values. 
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